We are international
• treatment options TEXT SIZE   
clinical trials    back

ASH 2011: Dr. Palumbo - Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study
Antonio Palumbo, MD
University of Torino
AOU S. Giovanni Battista
Torino, Italy

Be the first to comment

 related articles